Basic Information
| LncRNA/CircRNA Name | RP11-555H23.1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, other |
| Sample | GC tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | We further demonstrated that RP11-555H23.1 expression was significantly correlated with TNM stage (P = 0.038). The area under the ROC curve (AUC) was 0.65, and the specificity and sensitivity were 62% and 81%, respectively.Metabolic pathway-associated lncRNAs play an important role in the occurrence of gastric cancer, and metabolic pathway-associated lncRNAs, such as RP11-555H23.1, may represent novel biomarkers of gastric cancer. |
| Pubmed ID | 30320481 |
| Year | 2019 |
| Title | Global Expression Profiling of Metabolic Pathway-Related lncRNAs in Human Gastric Cancer and the Identification of RP11-555H23.1 as a New Diagnostic Biomarker |
External Links
| Links for RP11-555H23.1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |